Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02996084 : MS PATHS Normative Sub-Study
PhaseN/A
AgesMin: 21 Years Max: 60 Years
Eligibility
Key Inclusion Criteria

- Ability to understand the purpose and risks of the study and provide signed and dated
informed consent and authorization to use protected health information in accordance
with national and local participant privacy regulations.

Key Exclusion Criteria

- History of human immunodeficiency virus.

- Confirmed or suspected pregnancy.

- Diagnosis of migraine requiring medication or any other participant-reported diagnosis
of a neurological disease or condition (e.g., stroke, transient ischemic attack,
epilepsy, brain infection, brain surgery, prior head injury or concussion, or brain
tumor).

- Any participant-reported diagnosis of an autoimmune disorder (e.g., rheumatoid
arthritis, Sjögren's syndrome, scleroderma, or systemic lupus erythematosus).

- Standard MRI exclusion criteria, including claustrophobia, inability to lay still in
the magnet (e.g., tremor), or any type of implanted metal in the body that would be
affected by the strong magnetic field.

NOTE: Other protocol defined Inclusion/Exclusion criteria may apply
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02996084      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740